The proxy fight is escalating with both sides now in active solicitation. The annual meeting date is TBD but likely within 60-90 days. Monitor for ISS/Glass Lewis recommendations and any further proposal revisions. The stock trades at a deep discount to cash ($219.5M cash vs $97M market cap), making a proxy win by the activist or a sweetened bid the key catalysts. Short-term volatility expected through the vote.
Price Chart
Executive Summary
Seer, Inc. filed a DEFA14A (definitive additional proxy soliciting material) on May 22, 2026, confirming that its board unanimously rejected a further revised unsolicited acquisition proposal from the Radoff-JEC activist group (7.8% owner). The rejection follows the group's preliminary proxy filing to elect three director nominees and oppose management proposals at the 2026 annual meeting. This escalates the proxy fight, with the board defending its nominees and poison pill against an activist campaign citing severe value destruction.
Key Financial Metrics
Key Facts
- Board unanimously rejected further revised non-binding acquisition proposal from Radoff-JEC group dated May 14, 2026.
- Activist group (7.8% owner) previously filed preliminary proxy to elect three director nominees and oppose say-on-pay and poison pill ratification.
- Stock down ~97% since IPO; cumulative losses >$465M; Q1 revenue -34% YoY to $2.8M with $15.7M cash burn; market cap $92.4M vs $219.5M cash.
- Latest proposal was $2.40/share + CVR (42% premium to prior close) — rejected without engagement.
- DEFA14A filed as definitive additional materials under Rule 14a-12, signaling active solicitation by management.
Financial Impact
Activist group's latest proposal valued at $2.40/share + CVR (42% premium); market cap ~$97M vs $219.5M cash on hand.
Risk Factors
- Activist fails to win board seats — status quo continues with cash burn and no strategic change.
- Board continues to reject all proposals, leading to a prolonged stalemate and further value destruction.
- Poison pill (Tax Benefit Preservation Plan) ratification vote may fail, enabling activist to accumulate more shares.
- Annual meeting could be delayed, extending uncertainty.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-235525 |
| Document: 0001193125-26-235525-index-headers.html | 0001193125-26-235525 |
| Document: 0001193125-26-235525-index.html | 0001193125-26-235525 |
| Document: 0001193125-26-235525.txt | 0001193125-26-235525 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 6d ago | Press Release | $1.97 | awaiting T+20 | — | $1.96 (−0.51%) |
Oct 15, 2026 13d ago | ITC Section 337 | $2.03 | awaiting T+20 | — | $1.96 (−3.45%) |
Oct 8, 2026 19d ago | 3 | $2.19 | awaiting T+20 | — | $1.96 (−10.50%) |
Sep 21, 2026 5w ago | Press Release | $1.86 $2.02 | ▲ +8.60% | ▲ +9.51% | $1.96 (+5.38%) |
Jul 31, 2026 12w ago | 8-K | $2.22 $1.98 | ▼ −10.81% | ▼ −13.80% | $1.96 (−11.71%) |
Jul 28, 2026 13w ago | Press Release | $2.08 $2.02 | ▲ +2.88% | ▲ +7.90% | $1.96 (+5.77%) |
Jul 28, 2026 13w ago | DFAN14A | $2.14 $2.04 | ▼ −4.67% | ▼ −8.05% | $1.96 (−8.41%) |
Jul 20, 2026 14w ago | DEFA14A | $2.04 $2.03 | ▼ −0.49% | ▼ −4.61% | $1.96 (−3.92%) |
Jul 20, 2026 14w ago | Press Release | $2.04 $2.03 | ▼ −0.49% | ▼ −4.61% | $1.96 (−3.92%) |
Jul 8, 2026 15w ago | DEFA14A | $2.18 $2.19 | ▲ +0.46% | ▼ −2.81% | $1.96 (−10.09%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers